Transcription factor activity of STAT proteins: Structural requirements and regulation by phosphorylation and interacting proteins

Cellular and Molecular Life Sciences

Volumn 55, Issue 12, 1999, Pages 1535-1546

  Decker, T ^a   Kovarik, P ^a  

^a Vienna Biocenter   (Austria)

Author keywords

Gene; Phosphorylation; Promoter; STAT; Transcription

Indexed keywords

STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR;

CARBOXY TERMINAL SEQUENCE; DIMERIZATION; DNA BINDING; MAMMAL; NONHUMAN; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; DNA-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0032869581     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050393     Document Type: Review

References (116)

1. Lew D. J., Decker T., Strehlow I. and Darnell J. E. (1991) Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol. Cell. Biol. 11: 182-191
2. Decker T., Lew D. J., Mirkovitch J. and Darnell J. E. Jr (1991) Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor. EMBO J. 10: 927-932
3. Darnell J. E. Jr. Kerr I. M. and Stark G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264; 1415-1421
4. Schindler C. and Darnell J. F. Jr (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64: 621-651
5. Decker T., Kovarik P. and Meinke A. (1997) Gas elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17: 121-134
6. Mirkovitch J., Decker T. and Darnell J. F. Jr (1992) Interferon induction of gene transcription analysed by in vivo footprinting. Mol. Cell. Biol. 12: 1-9
7. Gouilleux F., Pallard C., Dusanter Fourt I., Wakao H., Haldosen L. A. Norstedt et al., (1995) Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 14: 2005-2013
8. Meinke A., Barahmand-pour F., Wöhrl S., Stoiber D. and Decker T. (1996) Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol. Cell. Biol. 16: 6937-6944
9. Durbin J. F., Hackenmiller R., Simon M. C. and Levy D. F. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 84: 443-450
10. Meraz M. A., White J. M., Sheehan K. C., Bach E. A., Rodig S. J., Dighe A. S. et al. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84: 431-442
11. Thierfelder W. E., Deursen J. M. van. Yamamoto K., Tripp R. A., Sarawar S. R., Carson R. T. et al. (1996) Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382: 171-174
12. Kaplan M. H., Sun Y. L., Hocy T. and Grusby M. J. (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382: 174-177
13. Shimoda K., Deursen J. van, Sangster M. Y., Sarawar S. R., Carson R. T., Tripp R. A. et al. (1996) Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630-633
14. Takeda K., Tanaka T., Shi W., Makoto M., Minami M., Kashiwamura S.-I. et al. (1996) Essential role of Stat6 in IL-4 signaling. Nature 380: 627-630
15. Liu X. W., Robinson G. W., Wagner K. U., Garrett L., Wynshawboris A. and Hennighausen L. (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11: 179-186
16. Teglund S., McKay C., Schuetz E., Deursen J. M. van, Stravopodis D., Wang D. et al. (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93: 841-850
17. Chen X. Vinkemeier U., Zhao Y., Jeruzalmi D., Darnell J. E. Jr and Kuriyan J. (1998) Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93: 827-839
18. Becker S., Groner B. and Muller C. W. (1998) Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 394: 145-151
19. Vinkemeier U., Moarefi I., Darnell J. E. Jr and Kuriyan J. (1998) Structure of the amino-terminal protein interaction domain of STAT-4. Science 279: 1048-1052
20. Schindler C., Fu X. Y., Improta T., Aebersold R. and Darnell J. L. Jr (1992) Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc. Natl. Acad. Sci. USA 89: 7836-7839
21. Fu X. Y., Schindler C., Improta T., Aebersold R. and Darnell J. F. (1992) The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl. Acad. Sci. USA 89: 7840-7843
22. Fu X. Y. (1992) A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s). Cell 70: 323-335
23. Mikita T., Daniel C., Wu P. and Schindler U. (1998) Mutational analysis of the STAT6 SH2 domain. J. Biol. Chem. 273: 17634-17642
24. Sasse J., Hemmann U., Schwartz C., Schniertshauer U., Heesel B., Landgraf C. et al. (1997) Mutational analysis of acute-phase response factor Stat3 activation and dimerization. Mol. Cell. Biol. 17: 4677-4686
25. Hemmann U., Gerhartz C. Heesel B., Sasse J., Kurapkat G., Grotzinger J. et al. (1996) Differential activation of acute phase response factor Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. H. Src homology SH2 domains define the specificity of stat factor activation. J. Biol. Chem. 271: 12999-13007
26. Heinrich P. C., Behrmann L., Muller-Newen G., Schaper F. and Graeve L. (1998) Interleukin-6-type cytokine signalling through the gp130, Jak STAT pathway. Biochem. J. 334: 297-314
27. Shuai K., Stark G. R., Kerr I. M. and Darnell J. E., Jr (1993) A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261: 1744-1746
28. Schaefer T. S., Sanders L. K., Park O. K. and Nathans D. (1997) Functional differences between Stat3alpha and Stat3beta. Mol. Cell. Biol. 17: 5307-5316
29. Caldenhoven E., Dijk T. B. van. Solari R., Armstrong J., Raaijmakers J. A. M., Lammers J. et al. (1996) STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J. Biol. Chem. 271: 13221-13227
30. Moriggl R., Gouilleux Gruart V., Jahne R., Berchtold S., Gartmann C., Liu X. et al. (1996) Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell. Biol. 16: 5691-5700
31. Mui A. L.-F., Wakao H., Kinoshita T., Kitamura T. and Miyajima A. (1996) Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat: role of Stat5 in proliferation. EMBO J. 15: 2425-2431
32. Mikita T., Campbell D., Wu P., Williamson K and Schindler U. (1996) Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol. Cell Biol. 16: 5811-5820
33. Azam M., Lee C., Strehlow I. and Schindler C. (1997) Functionally distinct isoforms of STAT5 arc generated by protein processing. Immunity 6: 691-701
34. Schaefer T. S., Sanders L. K. and Nathans D. (1995) Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc. Natl. Acad. Sci. USA 92: 9097-9101
35. Hoey T. and Schindler U. (1998) STAT structure and function in signaling. Curr. Opin. Genet. Dev. 8: 582-587
36. Ripperger J. A., Fritz S., Richter K., Hocke G. M., Lottspeich F. and Fey G. H. (1995) Transcription factors Stat3 and Stat5b are present in rat liver nuclei late in an acute phase response and bind interleukin-6 response elements. J. Biol. Chem. 270: 29998-30006
37. Wang D., Stravopodis D., Teglund S., Kitazawa J. and Ihle J. N. (1996) Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16: 6141-6148
38. Moriggl R., Berchtold S., Friedrich K., Standke G. J., Kammer W., Heim M. et al. (1997) Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol. Cell. Biol. 17: 3663-3678
39. Eilers A., Georgellis D., Klose B., Schindler C., Ziemiecki A., Harpur A. G. et al. (1995) Differentiation-regulated serine phosphorylation of STAT1 promotes GAF activation in macrophages. Mol. Cell. Biol. 15: 3579-3586
40. Lutticken C., Coffer P., Yuan J., Schwartz C., Caldenhoven E., Schindler C. et al. (1995) Interleukin-6-induced serine phosphorylation of transcription factor APRF: evidence for a role in interleukin-6 target gene induction. FEBS Lett. 360: 137-143
41. Boulton T. G., Zhong Z., Wen Z., Darnell J. E. Jr, Stahl N. and Yancopoulos G. D. (1995) STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA 92: 6915-6919
42. Zhang X., Blenis J., Li H. C., Schindler C. and Chen Kiang S. (1995) Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267: 1990-1994
43. Wen Z., Zhong Z. and Darnell J. E. Jr (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250
44. Wen Z. L. and Darnell J. E. (1997) Mapping of stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 25: 2062-2067
45. Zhu X. J., Wen Z. L., Xu L. Z. and Darnell J. E. (1997) Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol. Cell. Biol. 17: 6618-6623
46. Kovarik P., Stoiber D., Novy M. and Decker T. (1998) Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J. 17: 3660-3668
47. Chung J., Uchida E., Grammer T. C. and Blenis J. (1997) Stat3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 17: 6508-6516
48. Jain N., Zhang T., Fong S. L., Lim C. P. and Cao X. (1998) Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene 17: 3157-3167
49. Ng J. and Cantrell D. (1997) STAT3 is a serine kinase target in T lymphocytes: interleukin 2 and T cell antigen receptor signals converge upon serine 727. J. Biol. Chem. 272: 24542-24549
50. David M., Petricoin E. R., Benjamin C., Pine R., Weber M. J. and Lamer A. C. (1995) Requirement for MAP kinase (FRK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 269: 1721-1723
51. Takaoka A., Tanaka N., Mitani Y., Miyazaki T., Fujii H., Sato M. et al. (1999) Protein tyrosine kinase Pyk2 mediates the Jak-dependent MAPK and Stat1 pathways in the IFN-γ, but not IFN-α signalling. EMBO J. 18: 2480-2488
52. Nishiya T., Uehara T., Edamatsu H., Kaziro Y., Itoh H. and Nomura Y. (1997) Activation of Stat1 and subsequent transcription of inducible nitric oxide synthase gene in C6 glioma cells is independent of interferon gamma induced MAPK activation that is mediated by p21(ras). FEBS Lett. 408: 33-38
53. Cho S. S., Bacon C. M., Sudarshan C., Rees R. C., Finbloom D., Pine R. et al. (1996) Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 157: 4781-4789
54. Kirken R. A., Malabarba M. G., Xu J., Liu X. W., Farrar W. L., Hennighausen L. et al. (1997) Prolactin stimulates serine/tyrosine phosphorylation and formation of heterocomplexes of multiple Stat5 isoforms in Nb2 lymphocytes. J. Biol. Chem. 272: 14098-14103
55. Wartmann M., Cella N., Hofer P., Groner B., Liu X., Hennighausen L. et al. (1996) Lactogenic hormone activation of Stat5 and transcription of the beta-casein gene in mammary epithelial cells is independent of p42 ERK2 mitogen-activated protein kinase activity. J. Biol. Chem. 271: 31863-31868
56. Yamashita H., Xu J., Erwin R. A., Farrar W. L., Kirken R. A. and Rui H. (1998) Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells. J. Biol. Chem. 273: 30218-30224
57. Pircher T. J., Petersen H., Gustafsson J. A. and Haldosen L. A. (1999) Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a. Mol. Endocrinol. 13: 555-565
58. Beadling C., Ng J., Babbage J. W. and Cantrell D. A. (1996) Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J. 15: 1902-1913
59. Kirken R. A., Malabarba M. G., Xu J., Dasilva L., Erwin R. A., Liu et al. (1997) Two discrete regions of interleukin 2 (Il2) receptor beta independently mediate Il2 activation of a Pd98059/rapamycin/Wortmannin insensitive Stat5a/b serine kinase. J. Biol. Chem. 272: 15459-15465
60. O'Farrell A. M., Liu Y., Moore K. W. and Mui A. L. (1998) IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 17: 1006-1018
61. Onishi M., Nosaka T., Misawa K., Mui A. L., Gorman D., McMahon M. et al. (1998) Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18: 3871-3879
62. Kamogawa Y., Lee H. J., Johnston J. A., McMahon M., O'Garra A. and Arai N. (1998) A conditionally active form of STAT6 can mimic certain effects of IL-4. J. Immunol. 161: 1074-1077
63. Bromberg J. F., Horvath C. M., Wen Z., Schreiber R. D. and Darnell J. E. Jr (1996) Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. USA 93: 7673-7678
64. Horvath C. M. and Darnell J. E. Jr (1996) The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein. J. Virol. 70: 647-650
65. Vinkemeier U., Cohen S. L., Moarefi I., Chait B. T., Kuriyan J. and Darnell J. E. Jr (1996) DNA binding of in vitro activated Stat1 alpha. Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO. J. 15: 5616-5626
66. Barahmand-Pour F., Meinke A., Groner B. and Decker T. (1998) Jak2-Stat5 interactions analyzed in yeast. J. Biol. Chem. 273: 12567-12575
67. Bergad P. L., Shih H. M., Towle H. C., Schwarzenberg S. J. and Berry S. A. (1995) Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites. J. Biol. Chem. 270: 24903-24910
68. Meyer W. K., Reichenbach P., Schindler U., Soldaini E. and Nabholz. M. (1997) Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription. J. Biol. Chem. 272: 31821-31828
69. Xu X., Sun Y. L. and Hoey T. (1996) Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273: 794-797
70. Verdier F., Rabionet R., Gouilleux F., Beisenherz-Huss C., Varlet P., Muller O. et al. (1998) A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol. Cell. Biol. 18: 5852-5860
71. John S., Vinkemeier U., Soldaini E., Darnell J. E. Jr and Leonard W. J. (1999) The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell. Biol. 19: 1910-1918
72. Liu X., Gallego M. I., Smith G. H., Robinson G. W. and Hennighausen L. (1998) Functional release of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b. Cell Growth Differ. 9: 795-803
73. Muhlethaler-Mottet A., Di Berardino W., Otten L. A. and Mach B. (1998) Activation of the MHC class II transactivator CHTA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity 8: 157-166
74. Perez C., Coeffier E., Moreau Gachelin F., Wietzerbin J. and Benech P. D. (1994) Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor. Mol. Cell. Biol. 14: 5023-5031
75. Mikita T., Kurama M. and Schindler U. (1998) Synergistic activation of the germline epsilon promoter mediated by Stat6 and C/EBP beta. J. Immunol. 161: 1822-1828
76. Pine R. (1997) Convergence of TNFα and IFNγ signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS7kB element. Nucleic Acids Res. 25: 4346-4354
77. Ohmori Y., Schreiber R. D. and Hamilton T. A. (1997) Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J. Biol. Chem. 272: 14899-14907
78. Stocklin E., Wissler M., Gouilleux F. and Groner B. (1996) Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383: 726-728
79. Cella N., Groner B. and Hynes N. E. (1998) Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocorticoid receptor in mammary cells. Mol. Cell. Biol. 18: 1782-1793
80. Lechner J., Welte T., Tomasi J. K., Bruno P., Cairns C., Gustafsson J. et al. (1997) Promoter-dependent synergy between glucocorticoid receptor and Stat5 in the activation of beta-casein gene transcription. J. Biol. Chem. 272: 20954-20960
81. Arias J., Alberts A. S., Brindle P., Claret F. X., Smeal T., Karin M. et al. (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370: 226-229
82. Goldman P. S., Tran V. K. and Goodman R. H. (1997) The multifunctional role of the co-activator CBP in transcriptional regulation. Recent Progr. Harm. Res. 52: 103-119
83. Shibata H., Spencer T. E., Onate S. A., Jenster G., Tsai S. Y., Tsai M. J. et al. (1997) Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Progr. Horm. Res. 52: 141-164
84. Kadonaga J. T. (1998) Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 92: 307-313
85. Bannister A. J. and Kouzarides T. (1996) The CBP co-activator is a histone acetyltransferase. Nature 384: 641-643
86. Ogryzko V. V., Schiltz R. L., Russanova V., Howard B. H. and Nakatani Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959
87. Yang X. J., Ogryzko V. V., Nishikawa J., Howard B. H. and Nakatani Y. (1996) A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382: 319-324
88. Korzus E., Torchia J., Rose D. W., Xu L., Kurokawa R., McInerney E. M. et al. (1998) Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279: 703-707
89. Bhattacharya S., Eckner R., Grossman S., Oldread E., Arany Z., D'Andrea A. et al. (1996) Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383: 344-347
90. Zhang J. J., Vinkemeyer U., Gu W., Chakravarti D., Horvath C. M. and Darnell J. E. Jr (1996) Two contact regions between Stat1 and CBP/p300 in interferon g signaling. Proc. Natl. Acad. Sci. USA 93: 15092-15096
91. Kurokawa R., Kalafus D., Ogliastro M. H., Kioussi C., Xu L., Torchia J. et al. (1998) Differential use of CREB binding protein-coactivator complexes. Science 279: 700-703
92. Horvai A. E., Xu L., Korzus E., Brard G., Kalafus D., Mullen T. M. et al. (1997) Nuclear integration of jak/stat and ras/ap 1 signaling by cbp and p300. Proc. Natl. Acad. Sci. USA 94: 1074-1079
93. Ricote M., Li A. C., Willson T. M., Kelly C. J. and Glass C. K. (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82
94. Jiang C., Ting A. T. and Seed B. (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86
95. Darnell J. E. Jr (1997) STATs and gene regulation. Science 277: 1630-1635
96. Gutch M. J. and Reich N. C. (1991) Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. USA 88: 7913-7917
97. Ackrill A. M., Foster G. R., Laxton C. D., Flavell D. M., Stark G. R. and Kerr I. M. (1991) Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res. 19: 4387-4393
98. Look D. C., Roswit W. T., Frick A. G., Gris-Alevy Y., Dickhaus D. M., Walter M. J. et al. (1998) Direct suppression of Stat1 function during adenoviral infection. Immunity 9: 871-880
99. Chakravarti D., Ogryzko V., Kao H. Y., Nash A., Chen H., Nakatani Y. et al. (1999) A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96: 393-403
100. Nakashima K., Yanagisawa M., Arakawa H., Kimura N., Hisatsune T., Kawabata M. et al. (1999) Synergistic signaling in fetal brain by STAT3-smad1 complex bridged by p300. Science 284: 479-482
101. Pfitzner E., Jahne R., Wissler M., Stoecklin E. and Groner B. (1998) p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol. Endocrinol. 12: 1582-1593
102. Zhu M.-H., John S., Berg M. and Leonard W. J. (1999) Functional association of Nmi with Stat5 and Stat1 in IL-2 and IFN-g-mediated signaling. Cell 96: 121-130
103. Parker D., Ferreri K., Nakajima T., LaMorte V. J., Evans R., Koerber S. C. et al. (1996) Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol. Cell. Biol. 16: 694-703
104. Zhang J. J., Zhao Y., Chait B. T., Lathem W. W., Ritzi M., Knippers R. et al. (1998) Ser727-dependent recruitment of MCM5 by Stat1a in IFN-γ-induced transcriptional activation. EMBO J. 17: 6963-6971
105. Dutta A. and Bell S. P. (1997) Initiation of DNA replication in eukaryotic cells. Annu. Rev. Cell Dev. Biol. 13: 293-332
106. Luo G. and Yu-Lee L. (1997) Transcriptional inhibition by Stat5: differential activities at growth-related versus differentiation-specific promoters. J. Biol. Chem. 272: 26841-26849
107. Udy G. B., Towers R. P., Snell R. G., Wilkins R. J., Park S. H., Ram P. A. et al. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94: 7239-7244
108. Ohmori Y. and Hamilton T. A. (1997) Il-4-induced STAT6 suppresses IFN-gamma-stimulated STAT1-dependent transcription in mouse macrophages. J. Immunol. 159: 5474-5482
109. Bennett B. L., Cruz R., Lacson R. G. and Manning A. M. (1997) Interleukin-4 suppression of tumor necrosis factor alpha-stimulated F-selectin gene transcription is mediated by STAT6 antagonism of NF-kappaB. J. Biol. Chem. 272: 10212-10219
110. Kim T. K. and Maniatis T. (1996) Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science 273: 1717-1719
111. Haspel R. L., Salditt-Georgieff M. and Darnell J. E. Jr (1996) The rapid inactivation of nuclear tyrosine-phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J. 15: 6262-6268
112. David M., Grimley P. M., Finbloom D. S. and Larner A. C. (1993) A nuclear tyrosine phosphatase downregulates interferon-induced gene expression. Mol. Cell. Biol. 13: 7515-7521
113. Shuai K., Liao J. and Song M. M. (1996) Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol. Cell. Biol. 16: 4932-4941
114. Chung C. D., Liao J., Liu B., Rao X., Jay P., Berta P. et al. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278: 1803-1805
115. Liu B., Liao J., Rao X., Kushner S. A., Chung C. D., Chang D. D. et al. (1998) Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95: 10626-10631
116. Wong A. H., Tam N. W., Yang Y. L., Cuddihy A. R., Li S., Kirchhoff S. et al. (1997) Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16: 1291-1304